Page last updated: 2024-10-31

methylphenidate and Hematologic Diseases

methylphenidate has been researched along with Hematologic Diseases in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CROIZAT, P1
REVOL, L1
PALIARD, P1
BOTHIER, F1
BRUNAT, M1

Other Studies

1 other study available for methylphenidate and Hematologic Diseases

ArticleYear
[Trial of 6-methylprednisolone sodium hemisuccinate (Solumedrol) by the intravenous route in the treatment of malignant blood diseases in adults].
    Lyon medical, 1962, Jun-17, Volume: 94

    Topics: Hematologic Diseases; Humans; Injections, Intravenous; Methylphenidate; Methylprednisolone; Methylpr

1962